Reactivation of Epstein–Barr Virus Presenting as Massive Splenomegaly after Initiation of Golimumab Treatment
Epstein–Barr virus infection is most commonly asymptomatic in the acute setting, where the end result of infection is the adoption of a viral latency phenotype. The virus can reactivate later in life leading to the abnormal proliferation of the infected B, T, or NK cells. Hereby, we report a 71-year...
Saved in:
| Main Authors: | Anthony J. Febres-Aldana, Christopher A. Febres-Aldana, Kathrin Dvir, Gliceida Galarza-Fortuna, Michael Schwartz, Ana M. Medina, Vathany Sriganeshan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2020/3641813 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Massive Splenomegaly
by: Meagan Mayo, et al.
Published: (2023-02-01) -
Onset of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis triggered by sudden reactivation of asymptomatic latent Epstein-Barr virus infection
by: Masanari Mizuki, et al.
Published: (2025-07-01) -
What could cause the reactivation of Epstein-Barr virus in individuals with long COVID
by: Jiaxin Ling, et al.
Published: (2025-08-01) -
Sarcoidosis presenting with massive splenomegaly: 2 cases without pulmonary involvement
by: Md. Sadiqul Islam, MBBS, FCPS, et al.
Published: (2025-10-01) -
Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report
by: Michele Colaci, et al.
Published: (2011-01-01)